CD274 and non-small cell lung carcinoma: Regarding the correlation between KRAS mutations and PD-L1 expression, a recent contribution of our group reported the potential role played by the KRAS c.34G > T (p.G12C) variant in the prolonged survival found in NSCLC patients showing a PD-L1 overexpression [109].